Compare TEVA & HEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | HEI |
|---|---|---|
| Founded | 1901 | 1957 |
| Country | Israel | United States |
| Employees | 32842 | 11100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7B | 42.4B |
| IPO Year | N/A | N/A |
| Metric | TEVA | HEI |
|---|---|---|
| Price | $29.66 | $272.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $37.38 | ★ $365.58 |
| AVG Volume (30 Days) | ★ 6.7M | 703.9K |
| Earning Date | 04-29-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.09% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.98 |
| Revenue Next Year | $2.51 | $8.53 |
| P/E Ratio | ★ $28.19 | $69.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $229.07 |
| 52 Week High | $37.35 | $361.69 |
| Indicator | TEVA | HEI |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 29.71 |
| Support Level | $28.38 | N/A |
| Resistance Level | $31.99 | $323.02 |
| Average True Range (ATR) | 0.99 | 7.59 |
| MACD | -0.02 | -1.51 |
| Stochastic Oscillator | 42.11 | 4.34 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Heico is an aerospace and defense supplier that focuses on creating replacement parts for commercial aircraft and components for defense products. In commercial aerospace, Heico is the largest independent producer of replacement aircraft parts. In the defense market, the company produces niche subcomponents used in targeting technology as well as simulation equipment, among other categories. It operates as two segments: the flight support group and the electronic technologies group. Both supply the aerospace and defense sectors to different degrees. Heico is persistently acquisitive, focusing on companies in similar or adjacent markets that offer strong cash flow and profitable growth potential.